Medpace Holdings Inc (MEDP)
Working capital turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 1,883,940 | 1,519,300 | 1,145,160 | 926,439 | 860,388 |
Total current assets | US$ in thousands | 593,828 | 333,962 | 690,912 | 473,651 | 317,028 |
Total current liabilities | US$ in thousands | 925,131 | 803,470 | 557,217 | 440,110 | 343,002 |
Working capital turnover | — | — | 8.57 | 27.62 | — |
December 31, 2023 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,883,940K ÷ ($593,828K – $925,131K)
= —
The working capital turnover ratio for Medpace Holdings Inc was not available for the years 2023 and 2019. However, for the years 2022, 2021, and 2020, the company had working capital turnover ratios of 8.54, 27.61, and not available, respectively.
The working capital turnover ratio measures how efficiently a company utilizes its working capital to generate sales revenue. A higher ratio typically indicates that the company is effectively managing its working capital and generating sales from its assets.
In the case of Medpace Holdings Inc, the steep decline in the working capital turnover ratio from 27.61 in 2020 to 8.54 in 2021 raises concerns about the company's efficiency in utilizing its working capital to generate sales. It may imply that the company is not efficiently managing its working capital or experiencing difficulties in converting its current assets into sales.
Further analysis would be needed to understand the reasons behind this significant decrease in the working capital turnover ratio and to assess the overall financial health and operational efficiency of Medpace Holdings Inc.
Peer comparison
Dec 31, 2023